The subject of “Stable Coronary Artery Disease” resides at the heart of cardiovascular medicine, demanding precision and expertise in the management of patients grappling with coronary artery disease (CAD). CAD, characterized by the accumulation of atherosclerotic plaque within the coronary arteries, presents a formidable clinical challenge. It necessitates a thorough evaluation of CAD risk in individual patients, leading to precise categorization into risk strata: low, intermediate, or high. This rigorous risk stratification serves as the foundation upon which clinical decisions regarding diagnostic and therapeutic strategies are carefully constructed.
In the dynamic landscape of stable CAD, the pivotal dilemma revolves around the deliberate choice between non-invasive and invasive strategies. This crucial decision-making process takes into account an array of factors, encompassing the patient’s clinical presentation, the severity of symptoms, and the outcomes of diagnostic assessments. Particularly noteworthy is the consideration that individuals identified with a high probability of CAD become prime candidates for coronary angiography, an invasive procedure that provides unparalleled insights into coronary anatomy. This, in turn, refines subsequent therapeutic interventions, encompassing precise measures such as percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG).
